Centenial Surgical Suture Intrinsic Value

CSURGSU • Healthcare
Current Stock Price
₹99.80
Primary Intrinsic Value
₹124.00
Market Cap
₹49.9 Cr
+100.0% Upside
Median Value
₹199.60
Value Range
₹120 - ₹250
Assessment
Trading Below Calculated Value
Safety Margin
50.0%

CSURGSU Valuation Methods Summary

Method Type Intrinsic Value Range Upside/Downside Details
Book Value Method asset ₹124.00 ₹111.60 - ₹136.40 +24.2% Book Value/Share: ₹62.00, P/B: 2.0x
Revenue Multiple Method revenue ₹199.60 ₹179.64 - ₹219.56 +100.0% Revenue/Share: ₹104.00, P/S: 2.0x
EBITDA Multiple Method earnings ₹120.00 ₹108.00 - ₹132.00 +20.2% EBITDA: ₹6.00Cr, EV/EBITDA: 10x
Simple DCF (5Y) dcf ₹249.50 ₹199.60 - ₹299.40 +150.0% CF Growth: 15.0%, Discount: 15%
Method Types: Earnings Asset DCF Growth Dividend Conservative

Want to compare with current market value? Check CSURGSU share price latest .

Valuation Comparison Chart

CSURGSU Intrinsic Value Analysis

What is the intrinsic value of CSURGSU?

Based on our comprehensive analysis using 4 different valuation methods, the estimated intrinsic value of Centenial Surgical Suture (CSURGSU) is ₹199.60 (median value). With the current market price of ₹99.80, this represents a +100.0% variance from our estimated fair value.

The valuation range spans from ₹120.00 to ₹249.50, indicating ₹120.00 - ₹249.50.

Is CSURGSU undervalued or overvalued?

Based on our multi-method analysis, Centenial Surgical Suture (CSURGSU) appears to be trading below calculated value by approximately 100.0%.

Financial Health Analysis

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Current Ratio 2.86 Industry Standard: 2.0+ Above 2.0 Measures short-term liquidity capacity
Debt to Equity Ratio 2.74 Industry Standard: <0.5 Above 1.0 Indicates financial leverage level
Return on Equity -6.5% Industry Standard: 15%+ Below 10% Measures shareholder return efficiency
Operating Margin 10.0% Industry Standard: 20%+ Above 10% Indicates operational efficiency level
Asset Turnover Ratio 0.61x Industry Standard: 1.0x+ Above 0.5x Measures asset utilization efficiency

Cash Flow Quality Analysis

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2025 ₹17 Cr ₹11 Cr Positive Free Cash Flow 8/10
March 2024 ₹6 Cr ₹2 Cr Positive Free Cash Flow 7/10
March 2023 ₹1 Cr ₹1 Cr Positive Free Cash Flow 8/10
March 2022 ₹5 Cr ₹5 Cr Positive Free Cash Flow 8/10
March 2021 ₹2 Cr ₹2 Cr Positive Free Cash Flow 8/10